National conference on rare diseases (NAKSE)

For this purpose, representatives of patient organizations, clinics and centers for rare diseases, science and research, health insurance companies, the pharmaceutical industry and politics will come together in Berlin on September 28 and 29, 2023. We at SKC aim to support patients with rare diseases in gaining access to effective treatment. Dr. Ingo Hantke, manager market access, Steven Krüger, medical writer and Prof. Matthias P. Schönermark M.D., Ph.D., founder and managing partner, have holistically examined the topic "Orphan vs. non-orphan drugs in Germany - Is there really a need for adjustment in the benefit assessment?". We are already looking forward to presenting the scientific results with a poster during NAKSE. You can download the poster free of charge here.

Drugs for rare diseases, so-called orphan drugs, and their specific challenges in market access are among our core competencies. Stay up to date with our orphan tracker and our podcast "The Profcast - rare diseases and their therapies". We are the market access special forces.

Source:

• Achse - NAKSE